✨ Your Portfolio is fetched and updated from zerodha.
Hospitals

Gaudium IVF and Women Health Ltd.

GAUDIUMIVF

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹0 Cr.
P/E
0.00

Gaudium IVF and Women Health Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
-
PE
PE
-
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
41.31
ROCE (%)
ROCE (%)
53.59
Div Yield (%)
Div Yield (%)
-
Sales
Sales
70.72 Cr
OPM (%)
OPM (%)
0.41 %
Debt to Equity
Debt to Equity
0.41
View more
Edit Ratio's

About

Gaudium IVF and Women Health offers a range of fertility treatments including IVF, IUI, ICSI, … Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

4 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

8 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • ARPU - In Patient (Rs)
      Source

    FAQs on Gaudium IVF and Women Health Ltd. Business

    Gaudium IVF and Women Health is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

    Gaudium IVF & Women major competitors are .
    Market Cap of Gaudium IVF & Women is ₹0 Crs.
    While the median market cap of its peers are ₹0 Crs.

    Gaudium IVF & Women seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Hospitals
    Inside India’s Healthcare Stack: Capex-Heavy Hospitals, Supply Gaps & Venture-Scale Hospital Alts - Asymmetric
    Hospital Sector - The Economics of CapEx - Abhay Sahukar
    Impact on compeitition like TATA1MG on Diagnostics Sector - Aditya Khemka(Incred) - Bloomberg Quint
    Diagnostic Industry - P2P Analysis - SOIC
    How The Diagnostics Industry Works - PPFAS
    A thread on the Medical Tourism in India - Aditya Kondawar
    Effect Of Lease Accounting Changes & Why Debt To Equity Is Rising - SOIC
    Medical Costs - India vs Abroad - Trade Brains
    Hospital Sector Deep Dive! Part 7 - Stock preference in India Hospital Space - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 3 - Unit Economics, IRR of Hospital bus., Doctor Engagement Models - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 2 - Who pays our bills? Payor mix, Profitability of payor types - Harshit Toshniwal
    Case Mix Of Hospitals - Harshit Toshniwal
    The Business Model of Indian Hospitals Simplified - Anish Moonka
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material